Publication | Closed Access
Bevacizumab Revisited: Its Use in Different Mouse Models of Ocular Pathologies
29
Citations
56
References
2014
Year
Our findings consistently demonstrate that bevacizumab is as effective as the murine anti-VEGF-R2 antibody (DC101) in mouse models of CNV, OIR and GFS, thus confirming its suitability for translational ophthalmological research.
| Year | Citations | |
|---|---|---|
Page 1
Page 1